The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
Abstract
BACKGROUND: Patients with a single episode of neurologic dysfunction and brain magnetic resonance imaging (MRI) scans suggestive of multiple sclerosis are at high risk for clinically definite multiple sclerosis, but the outcome for individual patients is unpredictable. An increased risk of progression to clinically definite multiple sclerosis in patients with serum antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) has been reported. METHODS: We measured serum anti-MOG and anti-MBP IgG and IgM antibodies in 462 patients with a first clinical event suggestive of multiple sclerosis and at least two clinically silent lesions on brain MRI. The patients were participating in a multicenter trial of treatment with interferon beta-1b. Antibodies were assessed by Western blot analysis at baseline, and the results compared with the time and rate of progression to clinically definite multiple sclerosis or a diagnosis of multiple sclerosis as defined by an international panel (the McDonald criteria). Regular visits were scheduled for the assessment of neurologic impairment and for MRI before treatment and at months 3, 6, 9, 12, 18, and 24. RESULTS: No associations were found between the presence of anti-MOG and anti-MBP IgM and IgG antibodies and progression to clinically definite multiple sclerosis or a diagnosis of multiple sclerosis according to the McDonald criteria, either in the entire cohort or in any subgroups of the study population. CONCLUSIONS: Serum antibodies against MOG and MBP, as detected by Western blot analysis, are not associated with an increased risk of progression to clinically definite multiple sclerosis in patients who have had a clinically isolated syndrome suggestive of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Self-citationBiology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Kappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237641.33768.8d · Cited by 681
Self-citationBerger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., & Reindl, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022328 · Cited by 616
Kappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.003 · Cited by 549
Self-citationStorch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 522
Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J., & Linington, C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10930.x · Cited by 409
Schluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 371
Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W., & Berger, T. (1999) · Brain · doi:10.1093/brain/122.11.2047 · Cited by 347
A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody
Linnington, C., Webb, M., & Woodhams, P. L. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90064-x · Cited by 321
Lalive, P. H., Menge, T., Delarasse, C., Della Gaspera, B., Pham-Dinh, D., Villoslada, P., von Büdingen, H.-C., & Genain, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510672103 · Cited by 173
Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein
O’Connor, K. C., Appel, H., Bregoli, L., Call, M. E., Catz, I., Chan, J. A., Moore, N. H., Warren, K. G., Wong, S. J., Hafler, D. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1974 · Cited by 168
de Rosbo, N. K., Honegger, P., Lassmann, H., & Matthieu, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04173.x · Cited by 166
Marta, C. B., Oliver, A. R., Sweet, R. A., Pfeiffer, S. E., & Ruddle, N. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504979102 · Cited by 155
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects
Lampasona, V., Franciotta, D. M., Furlan, R., Zanaboni, S., Fazio, R., Bonifacio, E. E., Comı, G., & Martino, G. (2004) · Neurology · doi:10.1212/01.wnl.0000127615.15768.ae · Cited by 145
O’Connor, K. C., Chitnis, T., Griffin, D. E., Piyasirisilp, S., Bar‐Or, A., Khoury, S. J., Wucherpfennig, K. W., & Hafler, D. A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00002-x · Cited by 98
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis
Lim, E. T., Berger, T., Reindl, M., Dalton, C. M., Fernando, K., Keir, G., Thompson, E. J., Miller, D. H., & Giovannoni, G. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1187sr · Cited by 91
Self-citationBonifacio, E. E., Lampasona, V., & Bingley, P. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2648 · Cited by 81
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
Lolli, F., Rovero, P., Chelli, M., & Papini, A. M. (2005) · Neurology · doi:10.1212/wnl.65.5.781-b · Cited by 72
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
Gaertner, S., de Graaf, K. L., Greve, B., & Weissert, R. (2004) · Neurology · doi:10.1212/01.wnl.0000147259.34163.33 · Cited by 68
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event
Rauer, S. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.077784 · Cited by 61
Mantegazza, R. (2004) · International Immunology · doi:10.1093/intimm/dxh056 · Cited by 61
Antimyelin Antibodies with No Progression to Multiple Sclerosis
Pelayo, R., Tintoré, M., Montalbán, X., Rovira, À., Espejo, C., Reindl, M., & Berger, T. (2007) · New England Journal of Medicine · doi:10.1056/nejmc062467 · Cited by 57
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
Kühle, J., Lindberg, R. L. P., Regeniter, A., Mehling, M., Hoffmann, F., Reindl, M., Berger, T., Radue, E. W., Leppert, D., & Kappos, L. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0299-4 · Cited by 55
Self-citation
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1195 · Cited by 740
Self-citationMyelin oligodendrocyte glycoprotein antibodies in neurological disease
Reindl, M., & Waters, P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 626
Miller, D. H., Chard, D. T., & Ciccarelli, O. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70274-5 · Cited by 507
Self-citation
Metadata
- Authors
- Kuhle, J., Pohl, C., Mehling, M., Edan, G., Freedman, M. S., Hartung, H.-P., Polman, C. H., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Dahms, S., Lindberg, R., Kappos, L., & Sandbrink, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-01-25
- Volume
- 356
- Issue
- 4
- Pages
- 371-378
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2037979244
- Cited by
- 255
- References
- 29
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.